Investigation Overview
February 17, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cynosure, Inc. (NASDAQ:CYNO), was announced concerning whether the takeover of Cynosure, Inc. by Hologic, Inc for $66.00 per share. is unfair to NASDAQ:CYNO stockholders. The investigation by a law firm concerns whether certain officers and directors of Cynosure, Inc. (...
You must register (for free) or login to view the entire investigation.